- NEWS EXPLAINER
First cell therapy for solid tumours heads to the clinic: what it means for cancer treatment
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-024-00673-w
References
Rosenberg, S. A. et al. N. Engl. J. Med. 319, 1676–1680 (1988).
Chesney, J. et al. J. Immunother. Cancer 10, e005755 (2022).
Rohaan, M. W. et al. N. Engl. J. Med. 387, 2113–2125 (2022).
Guo, J. et al. J. Immunother. Cancer 10, e003887 (2022).
Creelan, B. C. et al. Nature Med. 27, 1410–1418 (2021).